Radiology Reimbursement Strategies
Understanding Radiology Reimbursement in 2026
For dialysis circuit angioplasty, the current Medicare Facility Fee stands at $1,820, with an additional Professional Fee of $320, bringing the total to $2,140. In comparison, the commercial facility median is significantly higher at $1,586. This gap highlights a crucial factor for interventional radiologists seeking to optimize practice economics: the disparity between Medicare and commercial insurance reimbursements. Referral Pulse can provide deeper insights into patient referral dynamics impacting these figures.
Analyzing the Data: A Financial Overview
Using the CMS Machine Readable Files and OPPS 2026 payment schedules as our foundation, we see clear economic trends in radiology. Let’s examine three key procedures:
| Procedure | Medicare Facility Fee | Medicare Professional Fee | Total Medicare | Commercial Median Facility |
|---|---|---|---|---|
| Dialysis circuit angioplasty | $1,820 | $320 | $2,140 | $1,586 |
| Dialysis circuit stent placement | $2,140 | $390 | $2,530 | $5,423 |
| Dialysis circuit thrombectomy | $2,500 | $450 | $2,950 | $3,600 |
These figures suggest a pronounced advantage for practices that can effectively negotiate commercial rates or increase patient volumes from commercial payers. The CenterIQ Practice Economics tool helps practices identify such opportunities, ensuring that revenue maximization aligns with patient care standards.
Maximizing Revenue in an Outpatient Setting
For outpatient-based labs (OBLs), understanding the difference in revenue potential compared to hospital-based interventional radiology (HospIR) is crucial. For example, the OBL Medicare revenue for dialysis circuit angioplasty is $1,820, compared to a hospital setting. Meanwhile, commercial revenues in OBLs can surpass hospital settings, as seen with dialysis circuit stent placement, where the commercial median is $5,423 versus $2,140 for Medicare.
Strategic Implementation
To successfully navigate these economic landscapes, radiologists must focus on both strategic procedure selection and targeted contractual negotiations with commercial insurers. The data clearly indicates the financial benefits of optimizing both Medicare and commercial payer mixes in practice.
Conclusion
In summary, navigating the complex reimbursement landscape in radiology requires a robust understanding of both Medicare and commercial payer dynamics. Physicians evaluating radiology reimbursement strategies can enhance their financial viability by leveraging data-driven insights and strategic tools available through GigHz Clinical Tools.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — April 26, 2026
